Spin-out profile: CHARNWOOD MOLECULAR
Charnwood Molecular is a leading provider of synthetic organic chemistry services for many industry sectors including the chemical, pharmaceutical and biotechnology industries.
BACKGROUND
Established in 1998, Charnwood Molecular’s experienced postdoctoral chemists work in state of the art laboratories researching and developing new synthetic chemistry processes and making novel organic compounds. With a turnover of over 1m, the company is already well established.
SERVICES
Charnwood Molecular has particular research strengths and experience in heterocyclic chemistry and asymmetric synthesis. This is complemented by excellent analytical capabilities and large scale laboratory facilities for the preparation of large samples.
The company’s services include medicinal chemistry, computer aided drug design, custom synthesis, contract research and solid phase organic synthesis. Charnwood Molecular offers its services for research and development, undertaking projects tailored to the specific requirements of the client. This includes medicinal chemistry support to the pharmaceutical and biotechnology industries. The medicinal chemists at Charnwood Molecular have experience of working in various therapeutic areas including oncology, obesity, immunology and the treatment of cardiovascular diseases.
Charnwood Molecular also provide expert Computer-Aided Molecular Design (CAMD), which has become a keystone within the drug discovery process, bridging the skills of biologists and chemists and helping to promote inter-disciplinary communication.
FORWARD STRATEGY
Charnwood Molecular already has established sales in the UK, and aims to expand into Europe to exploit the worldwide appeal of their services.
CONTACT DETAILS
Charnwood Molecular Ltd
The Heritage Building
7 Beaumont Court
Prince William Road
Loughborough
LE11 5GA
T: +44 (0)1509 232007
Fax: +44 (0)1509 260009
E: derek.faries@charnwood-molecular.com